Related Experiment Video

Updated: Jul 28, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.0K

Editorial: Modeling neuromuscular diseases to determine molecular drivers of pathology and for drug discovery

Alec S T Smith1,2, Megan L McCain3,4, Mark Bothwell1,2

  • 1Department of Physiology and Biophysics, University of Washington, Seattle, WA, United States.

Frontiers in Cell and Developmental Biology
|October 24, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cell line (C2C12)disease modelingiPSC (induced pluripotent stem cell)in vitro versus in vivoneuromuscular disease (NMD)therapy screening

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.7K
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.4K

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...